EUROPEAN BIOTECH ACQUTN CORP's ticker is EBAC and the CUSIP is G3167F102. A total of 32 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,989 | -99.9% | 593,018 | -0.6% | 0.00% | 0.0% |
| Q3 2022 | $5,912,000 | +1.2% | 596,572 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $5,840,000 | +0.1% | 596,572 | -0.4% | 0.00% | +33.3% |
| Q1 2022 | $5,835,000 | +394.1% | 599,127 | +345.6% | 0.00% | +200.0% |
| Q4 2021 | $1,181,000 | -6.7% | 134,468 | -6.3% | 0.00% | 0.0% |
| Q3 2021 | $1,266,000 | -13.6% | 143,481 | -12.2% | 0.00% | 0.0% |
| Q2 2021 | $1,465,000 | – | 163,481 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Arena Capital Advisors, LLC- CA | 300,899 | $2,928,000 | 0.23% |
| Exos Asset Management LLC | 45,300 | $438,000 | 0.23% |
| Athanor Capital, LP | 147,800 | $1,429,000 | 0.19% |
| MMCAP International Inc. SPC | 250,000 | $2,418,000 | 0.17% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 65,689 | $637,000 | 0.08% |
| Atalaya Capital Management LP | 40,000 | $387,000 | 0.06% |
| Radcliffe Capital Management, L.P. | 200,000 | $1,946,000 | 0.06% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 300,000 | $2,901,000 | 0.05% |
| FIR TREE CAPITAL MANAGEMENT LP | 150,000 | $1,451,000 | 0.05% |
| Ghisallo Capital Management LLC | 125,000 | $1,214,000 | 0.05% |